Thermo Fisher Scientific stock gains 1.03 percent on results
Published on 09/24/2026 at 14:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Thermo Fisher Scientific stock stood at USD 665.30 on the NYSE on September 23, 2026, up 1.03 percent for the session. The move followed second-quarter results showing 10 percent revenue growth to USD 11.99 billion and a 13 percent increase in adjusted EPS to USD 6.03, according to Fortune.
Revenue reaches USD 11.99 billion
The second-quarter performance restored 5 percent organic growth, while adjusted operating income grew 15 percent to USD 2.73 billion. Adjusted operating margin expanded by 90 basis points to 22.8 percent, creating operating leverage alongside the stronger top line, according to Fortune.
GAAP earnings per share reached USD 4.68 in Q2 2026, compared with USD 4.28 in the same quarter of 2025. That 9 percent increase gives the latest adjusted result a useful cross-check against the reported earnings trend, according to Yahoo Finance.
Guidance moves higher
Management raised full-year 2026 revenue guidance to USD 47.4 billion-48.1 billion and adjusted EPS guidance to USD 24.93-25.33. The EPS range implies 9 percent-11 percent growth over 2025, while the midpoint increased by USD 0.25 from the previous outlook, according to Fortune.
The combination of 5 percent organic growth and higher full-year guidance matters because it links the quarterly beat to a broader demand recovery in pharma and biotech customers. Thermo Fisher's latest investor materials describe the company as serving research, diagnostics, analytical instruments and biopharma services across its global platform.
Stock trades near yearly high
The USD 665.30 price was USD 6.17 below the 52-week high of USD 671.47 on September 23, 2026, a gap of 0.92 percent. The 52-week low was USD 435.27, while market capitalization stood at USD 245.99 billion on September 24, 2026.
Thermo Fisher Scientific stock facts
- Company: Thermo Fisher Scientific Inc.
- Ticker: TMO
- Trading venue: NYSE
- Price: USD 665.30 on September 23, 2026
- Market capitalization: USD 245.99 billion as of September 24, 2026
- 52-week range: USD 435.27-671.47 as of September 23, 2026
- Sector / Industry: Healthcare / Medical - Diagnostics and Research
